{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:07:30Z","timestamp":1745467650073,"version":"3.40.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The International EARCO registry is funded by unrestricted grants of Grifols, CSL Behring, Kamada, pH Pharma, Sanofi and Takeda to the European Respiratory Society (ERS)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03651-8","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:17:10Z","timestamp":1745389030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of the Mmalton carrier\u2019s cohort within the EARCO (European Alpha- 1 Antitrypsin Research Collaboration) registry"],"prefix":"10.1186","volume":"25","author":[{"given":"Beatriz D.","family":"Ferraz","sequence":"first","affiliation":[]},{"given":"Maria","family":"Sucena","sequence":"additional","affiliation":[]},{"given":"Margarida Fonseca","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Alice M.","family":"Turner","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Mar\u00eda","family":"Hern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda","family":"Torres-Duran","sequence":"additional","affiliation":[]},{"given":"Hanan","family":"Tanash","sequence":"additional","affiliation":[]},{"given":"Carlota","family":"Rodr\u00edguez-Garc\u00eda","sequence":"additional","affiliation":[]},{"given":"Jens-Ulrik","family":"Jensen","sequence":"additional","affiliation":[]},{"given":"Angelo","family":"Corsico","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Luis","family":"L\u00f3pez-Campos","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Chapman","sequence":"additional","affiliation":[]},{"given":"Christian F.","family":"Clarenbach","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[]},{"given":"Beatriz","family":"Lara","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"36","key":"3651_CR1","doi-asserted-by":"publisher","first-page":"33293","DOI":"10.1074\/jbc.R100016200","volume":"276","author":"GA Silverman","year":"2001","unstructured":"Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PGW, et al. The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins. J Biol Chem. 2001;276(36):33293\u20136.","journal-title":"J Biol Chem"},{"issue":"163","key":"3651_CR2","doi-asserted-by":"publisher","first-page":"210262","DOI":"10.1183\/16000617.0262-2021","volume":"31","author":"M Miravitlles","year":"2022","unstructured":"Miravitlles M, Herepath M, Priyendu A, Sharma S, Vilchez T, Vit O, et al. Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews. Eur Respir Rev. 2022;31(163):210262.","journal-title":"Eur Respir Rev"},{"issue":"7","key":"3651_CR3","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1164\/rccm.168.7.818","volume":"168","author":"Society AT, Society ER","year":"2003","unstructured":"Society AT, Society ER. American Thoracic Society\/European Respiratory Society Statement. Am J Respir Crit Care Med. 2003;168(7):818\u2013900.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3651_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.arbres.2023.03.016","volume":"59","author":"I Blanco","year":"2023","unstructured":"Blanco I, Diego I, Casta\u00f1\u00f3n C, Bueno P, Miravitlles M. Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease. Arch Bronconeumol. 2023;59(7):427\u201334.","journal-title":"Arch Bronconeumol"},{"issue":"2","key":"3651_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/thorax.2003.006494","volume":"59","author":"M Luisetti","year":"2004","unstructured":"Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax. 2004;59(2):164\u20139. https:\/\/doi.org\/10.1136\/thorax.2003.006494.","journal-title":"Thorax."},{"issue":"1","key":"3651_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13023-024-03069-1","volume":"19","author":"I Ferrarotti","year":"2024","unstructured":"Ferrarotti I, Wencker M, Chorostowska-Wynimko J. Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review. Orphanet J Rare Dis. 2024;19(1):82.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3651_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1183\/09031936.06.00062305","volume":"27","author":"I Blanco","year":"2006","unstructured":"Blanco I, de Serres FJ, Fernandez-Bustillo E, Lara B, Miravitlles M. Estimated numbers and prevalence of PI*S and PI*Z alleles of 1-antitrypsin deficiency in European countries. Eur Respir J. 2006;27(1):77\u201384.","journal-title":"Eur Respir J"},{"issue":"10 HCC","key":"3651_CR8","doi-asserted-by":"publisher","first-page":"e7434","DOI":"10.5812\/hepatmon.7434","volume":"12","author":"I Blanco","year":"2012","unstructured":"Blanco I, de Serres FJ, C\u00e1rcaba V, Lara B, Fern\u00e1ndez-Bustillo E. Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method. Hepat Mon. 2012;12(10 HCC):e7434.","journal-title":"Hepat Mon."},{"issue":"1","key":"3651_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-4-12","volume":"4","author":"S Denden","year":"2009","unstructured":"Denden S, Zorzetto M, Amri F, Knani J, Ottaviani S, Scabini R, et al. Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report. Orphanet J Rare Dis. 2009;4(1):12.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3651_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/jmg.2004.023903","volume":"42","author":"I Ferrarotti","year":"2005","unstructured":"Ferrarotti I, Baccheschi J, Zorzetto M, Tinelli C, Corda L, Balbi B, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J M\u00e9d Genet. 2005;42(3):282.","journal-title":"J M\u00e9d Genet"},{"issue":"6","key":"3651_CR11","first-page":"844","volume":"44","author":"DW Cox","year":"1989","unstructured":"Cox DW, Billingsley GD. Rare deficiency types of alpha 1-antitrypsin: electrophoretic variation and DNA haplotypes. Am J Hum Genet. 1989;44(6):844\u201354 PMID: 2786333; PMCID: PMC1715659.","journal-title":"Am J Hum Genet."},{"issue":"3","key":"3651_CR12","doi-asserted-by":"publisher","first-page":"e00528","DOI":"10.1002\/rcr2.528","volume":"8","author":"M Aiello","year":"2020","unstructured":"Aiello M, Fantin A, Longo C, Ferrarotti I, Bertorelli G, Chetta A. Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency. Respirol Case Rep. 2020;8(3):e00528.","journal-title":"Respirol Case Rep."},{"issue":"23","key":"3651_CR13","doi-asserted-by":"publisher","first-page":"13938","DOI":"10.1016\/S0021-9258(18)80090-4","volume":"264","author":"DT Curiel","year":"1989","unstructured":"Curiel DT, Holmes MD, Okayama H, Brantly ML, Vogelmeier C, Travis WD, et al. Molecular Basis of the Liver and Lung Disease Associated with the \u03b11-Antitrypsin Deficiency Allele Mmalton. J Biol Chem. 1989;264(23):13938\u201345.","journal-title":"J Biol Chem"},{"key":"3651_CR14","first-page":"375","volume-title":"Protides of the Biological","author":"DW Cox","year":"1976","unstructured":"Cox DW. A new deficiency allele of alpha1-antitrypsin: Pi MMmalton. In: Peeters H, editor. Protides of the Biological Fluids, vol. 23. Oxford: Pergamon; 1976. p. 375\u20138."},{"key":"3651_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/ajcp\/82.4.424","volume":"82","author":"A RE","year":"1984","unstructured":"RE A, Cox DW, Medline A, Wanless IR. Occurrence of alphal-antitrypsin deficiency in 155 patients with alcoholic liver disease. Am J Clin Pathol. 1984;82:424\u20137.","journal-title":"Am J Clin Pathol."},{"issue":"6","key":"3651_CR16","first-page":"894","volume":"44","author":"GC Fraizer","year":"1989","unstructured":"Fraizer GC, Harrold TR, Hofker MH, Cox DW. In-frame single codon deletion in the Mmalton deficiency allele of alpha 1-antitrypsin. Am J Hum Genet. 1989;44(6):894\u2013902. PMID: 2786335; PMCID: PMC1715665.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"3651_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-023-02719-0","volume":"18","author":"IC Hageman","year":"2023","unstructured":"Hageman IC, van Rooij IALM, de Blaauw I, Trajanovska M, King SK. A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance. Orphanet J Rare Dis. 2023;18(1):106.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3651_CR18","doi-asserted-by":"publisher","first-page":"1900138","DOI":"10.1183\/13993003.00138-2019","volume":"53","author":"M Miravitlles","year":"2019","unstructured":"Miravitlles M, Chorostowska-Wynimko J, Ferrarotti I, McElvaney NG, O\u2019Hara K, Stolk J, et al. The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency. Eur Respir J. 2019;53(2):1900138.","journal-title":"Eur Respir J"},{"issue":"7","key":"3651_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","volume":"11","author":"JD Chalmers","year":"2023","unstructured":"Chalmers JD, Polverino E, Crichton ML, Ringshausen FC, Soyza AD, Vendrell M, et al. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023;11(7):637\u201349.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"3651_CR20","doi-asserted-by":"publisher","first-page":"00181","DOI":"10.1183\/23120541.00181-2019","volume":"6","author":"T Greulich","year":"2020","unstructured":"Greulich T, Altraja A, Barrecheguren M, Bals R, Chlumsky J, Chorostowska-Wynimko J, et al. Protocol for the EARCO Registry: a pan-European observational study in patients with \u03b11-antitrypsin deficiency. Erj Open Res. 2020;6(1):00181\u20132019.","journal-title":"Erj Open Res"},{"issue":"3","key":"3651_CR21","doi-asserted-by":"publisher","first-page":"2201949","DOI":"10.1183\/13993003.01949-2022","volume":"61","author":"M Miravitlles","year":"2023","unstructured":"Miravitlles M, Turner AM, Torres-Duran M, Tanash H, Rodr\u00edguez-Garc\u00eda C, L\u00f3pez-Campos JL, et al. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry. Eur Respir J. 2023;61(3):2201949.","journal-title":"Eur Respir J"},{"issue":"1","key":"3651_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12931-022-02275-4","volume":"23","author":"M Miravitlles","year":"2022","unstructured":"Miravitlles M, Turner AM, Torres-Duran M, Tanash H, Rodr\u00edguez-Garc\u00eda C, L\u00f3pez-Campos JL, et al. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry. Respir Res. 2022;23(1):352.","journal-title":"Respir Res"},{"issue":"3","key":"3651_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648\u201354.","journal-title":"Eur Respir J"},{"issue":"5","key":"3651_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.rmed.2008.12.005","volume":"103","author":"JJ Soler-Catalu\u00f1a","year":"2009","unstructured":"Soler-Catalu\u00f1a JJ, Mart\u00ednez-Garc\u00eda M\u00c1, S\u00e1nchez LS, Tordera MP, S\u00e1nchez PR. Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients. Respir Med. 2009;103(5):692\u20139.","journal-title":"Respir Med"},{"issue":"10","key":"3651_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.arbr.2017.08.007","volume":"53","author":"FM Bugallo","year":"2017","unstructured":"Bugallo FM, Gon\u00e7alves JMF, Mart\u00ednez MDM, P\u00e9rez DD. Spectrum of Alpha-1 Antitripsin Deficiency Mutations Detected in Tenerife. Arch Bronconeumol (Engl Ed). 2017;53(10):595\u20136.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"issue":"1","key":"3651_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1183\/09031936.00104712","volume":"42","author":"B Piras","year":"2012","unstructured":"Piras B, Ferrarotti I, Lara B, Martinez MT, Bustamante A, Ottaviani S, et al. Clinical phenotypes of Italian and Spanish patients with \u03b1 1 -antitrypsin deficiency. Eur Respir J. 2012;42(1):54\u201364.","journal-title":"Eur Respir J"},{"issue":"3","key":"3651_CR27","doi-asserted-by":"publisher","first-page":"00213","DOI":"10.1183\/23120541.00213-2022","volume":"8","author":"M Torres-Dur\u00e1n","year":"2022","unstructured":"Torres-Dur\u00e1n M, L\u00f3pez-Campos JL, Rodr\u00edguez-Hermosa JL, Esquinas C, Mart\u00ednez-Gonz\u00e1lez C, Hern\u00e1ndez-P\u00e9rez JM, et al. Demographic and clinical characteristics of patients with \u03b11-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO. ERJ Open Res. 2022;8(3):00213\u20132022.","journal-title":"ERJ Open Res"},{"issue":"1","key":"3651_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.rppnen.2017.11.004","volume":"24","author":"JMF Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves JMF, Bugallo FM, P\u00e9rez DD, Mart\u00ednez MDM, Garc\u00eda-Talavera I, P\u00e9rez RP. Clinical manifestations of the Mmalton alpha-1 antitrypsin deficiency variant. Pulmonology. 2018;24(1):48\u20139.","journal-title":"Pulmonology"},{"issue":"7","key":"3651_CR29","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/thx.41.7.568","volume":"41","author":"MB Allen","year":"1986","unstructured":"Allen MB, Ward AM, Perks WH. Alpha 1 antitrypsin deficiency due to MMaltonZ phenotype: case report and family study. Thorax. 1986;41(7):568.","journal-title":"Thorax"},{"issue":"1","key":"3651_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0016-5085(87)90332-5","volume":"93","author":"CL Reid","year":"1987","unstructured":"Reid CL, Wiener GJ, Cox DW, Richter JE, Geisinger KR. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of \u03b11-antitrypsin. Gastroenterology. 1987;93(1):181\u20137.","journal-title":"Gastroenterology"},{"issue":"1","key":"3651_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-015-0350-6","volume":"10","author":"P Joly","year":"2015","unstructured":"Joly P, Guillaud O, Hervieu V, Francina A, Mornex JF, Chapuis-Cellier C. Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states. Orphanet J Rare Dis. 2015;10(1):130.","journal-title":"Orphanet J Rare Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03651-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:17:11Z","timestamp":1745389031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3651"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03651-8","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received central ethics approval by the research ethics committee of the Vall d\u2019Hebron University Hospital of Barcelona, Spain (PR(AG)480\/2018) and was subsequently approved by all participating centres. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Beatriz D Ferraz has received speaker fees and support for attending meetings from CSL Behring. Maria Sucena has received consulting fees from Bial, GlaxoSmithKline, CSL Behring and Grifols, speaker fees from AstraZeneca, Bial, CSL Behring, Grifols, GlaxoSmithKline and Novartis, support for attending meetings from Bial, CSL Behring, Grifols and Medinfar, honoraria for participation on advisory board from Bial and CSL Behring.Alice M Turner has received either grants or speaker fees from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, CSL Behring, Takeda, Vertex, Alpha 1 Foundation and Grifols. Jos\u00e9 Mar\u00eda Hern\u00e1ndez- P\u00e9rez has received speaker fees from Bial, CSL Behring and GlaxoSmithKline, and support for attending meetings from Grifols and CSL Behring. Mar\u00eda Torres-Dur\u00e1n has received either grants or speaker fees from Grifols, IISCIII (Instituto de Investigaci\u00f3n Sanitaria Carlos III), IISGS (Instituo de Investigaci\u00f3n Sanitaria Galicia Sur), CSL Behring and GlaxoSmithKline, and support for attending meeting from FAES, Bial and Chiesi. Hanan Tanash has received speaker fees from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Chiesi and Grifols. Carlota Rodr\u00edguez-Garc\u00eda has received speaker fees from GlaxoSmithKline, Bial, AstraZeneca and CSL Behring, and support for attending meetings from Chiesi and Grifols.Angelo Corsico has received consulting fees from GlaxoSmithKline, Grifols, CSL Behring, Zambon and Bruschettini and support for attending meetings from AstraZeneca and Chiesi. Jos\u00e9 Luis L\u00f3pez-Campos has received honoraria during the last 3 years for lecturing, scientific advice, participation in clinical studies or writing for publications for (alphabetical order): AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, CSL Behring, Faes, Gebro Pharma, GlaxoSmithKline, Grifols, Menarini and Zambon.Kenneth Chapman has received grant or contracts from BMS, Bellus, AstraZeneca, GlaxoSmithKline, Sanofi, Regeneron, Takeda and Novartis, consulting fees from AstraZeneca, GSK, Inhibrix, Mereo, Regeneron, Sanofi and Takeda; speaking fees from Valeo, Sanofi, Novartis, GSK and Takeda. Christian F Clarenbach has received consulting fees from AstraZeneca, Boehringer Ingelheim, CSL Behring, Daiichi Synkyo, GlaxoSmithKline, Novartis, Sanofi, OM Pharma, MSD, Grifols and Vifor and speaking fees from AstraZeneca, Boehringer Ingelheim, CSL Behring, Daiichi Synkyo, GlaxoSmithKline, Novartis, Sanofi, OM Pharma, MSD and Grifols, Vifor.Joana Gomes has received speaker fees from AstraZeneca, GlaxoSmithKline, CSL Behring and Tecnimede and support for attending meetings from Tecnimede. Marc Miravitlles has received grants or contracts from Grifols speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Bial, GlaxoSmithKline, Menarini, Kamada, Takeda, Zambon, CSL Behring, Specialty Therapeutics, Janssen, Grifols, Zambon, Tabuk Pharmaceuticals, Glenmark Pharmaceuticals, Sanofi\/Regeneron and Novartis, support for attending meetings from Boehringer Ingelheim, Menarini, Chiesi, Bial, CSL Behring and Grifols and consulting fees AstraZeneca, Atriva Therapeutics, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, CSL Behring, Inhibrx, Ferrer, Menarini, Mereo Biopharma, Spin Therapeutics, Specialty Therapeutics, BridgeBio, AstraZeneca, Atriva Therapeutics, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, CSL Behring, Inhibrx, Ferrer, Menarini, Mereo Biopharma, Spin Therapeutics, Specialty Therapeutics, BridgeBio, Palobiofarma SL, Takeda, Novartis, Beam therapeutics, Novo Nordisk, Sanofi\/Regeneron, Zambon, Zentiva and Grifols. The remaining authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}